Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Wroclaw

951 clinical trials in Wroclaw, Poland across 13 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Wroclaw at a glance
951
clinical trials
  • Research sites13
Type of trial
Recruitment status
Quick filters

951 trials in Wroclaw

Open in trial search

Obesity+1

Recruiting

A Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Obesity+1

Recruiting

Efficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Diabetes mellitus+2

Recruiting

A Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Phase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years

Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.

A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited

Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Zai Lab (US) LLC

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Wroclaw

What the registry says about research in the country

01 Respiratory Diseases

Innovative clinical trials focusing on respiratory viral infections, including studies of vaccines against RSV and human metapneumovirus in older adults. Research includes evaluation of novel immunization approaches for influenza prevention and lower respiratory tract infections.

  • RSV vaccine development
  • Influenza prevention
  • Respiratory infection management
02 Dermatological Conditions

Comprehensive research into plaque psoriasis and related conditions, examining new therapeutic approaches including biologics and oral medications. Studies focus on both moderate to severe cases and specific manifestations like genital psoriasis.

  • Psoriasis treatment innovations
  • Psoriatic arthritis therapies
  • Biological response modifiers
03 Autoimmune Disorders

Groundbreaking trials investigating treatments for various autoimmune conditions, including Sjögren's disease and systemic sclerosis. Research focuses on novel therapeutic approaches and long-term disease management strategies.

  • Innovative antibody treatments
  • Disease-modifying therapies
  • Immunological interventions
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.